Please ensure Javascript is enabled for purposes of website accessibility

Aurora Cannabis Keeps Its Momentum Going in Q3

By Keith Speights - May 15, 2019 at 9:20AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Canadian cannabis producer delivered skyrocketing revenue growth but a widening net loss in the third quarter.

Aurora Cannabis (ACB 4.75%) has been on a roll so far in 2019. Several analysts have jumped on the Canadian marijuana stock's bandwagon, and Aurora was selected as one of only three companies to receive licenses to cultivate medical cannabis in Germany.

But the company's momentum was put to the test on Tuesday when Aurora announced its fiscal 2019 third-quarter results after the market closed. As it turned out, Aurora passed that test, delivering strong Q3 growth. Shares rose nearly 3% in after-hours trading Tuesday evening.

Magnifying glass on top of a marijuana leaf

Image source: Getty Images.

Aurora reported Q3 gross revenue of CA$75.2 million. This reflected a year-over-year increase of 367% and a quarter-over-quarter increase of 21%. Net revenue, which excludes excise taxes, came in at CA$65.1 million, up 305% year over year and 20% quarter over quarter. The consensus analysts' revenue estimate for Q3 was around CA$68.5 million.

The company announced a net loss in the third quarter of CA$158.4 million, or CA$0.16 per share. Aurora's bottom line improved from the second quarter net loss of CA$237.8 million but widened considerably from the net loss of CA$19.2 million reported in the prior-year period. The consensus analysts' estimate was for a loss of CA$0.04 per share.

Aurora's consumer net revenue in Q3 totaled CA$29.6 million, up 37% from the previous quarter. The company reported medical cannabis net revenue of CA$29.1 million, a year-over-year increase of 169% and a quarter-over-quarter increase of 12%.

As Chief Financial Officer Glen Ibbott hinted in the company's Q2 conference call, Aurora's production and shipments didn't slow down in the third quarter. The company's production volume in Q3 soared 99% from the previous quarter to 15,590 kilograms, with acceleration throughout the quarter.

Aurora expects that its production available for sale in the fourth quarter will exceed 25,000 kilograms. It also anticipates that operating costs will continue to decrease and that it will achieve positive EBITDA next quarter. "With a solid Q3 on all fronts, it's time to move the yardsticks for the industry again," Ibbott said, summing up Aurora's third quarter and its outlook. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$3.09 (4.75%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
338%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.